# Study of CM310 in Subjects With Seasonal Allergic Rhinitis

> **NCT06171074** · PHASE2 · UNKNOWN · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 100 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT06171074
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-30
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171074, "Study of CM310 in Subjects With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06171074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
